What are the health risks associated with vaping?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Health Risks of Vaping

Vaping poses significant health risks including e-cigarette or vaping product use-associated lung injury (EVALI), cardiovascular damage, respiratory problems, and nicotine addiction, with particular dangers for adolescents, pregnant women, and those with pre-existing conditions. 1

Respiratory System Risks

  • EVALI (E-cigarette or Vaping Product Use-Associated Lung Injury):

    • Caused over 2,800 hospitalizations and 68 deaths in 2019-2020 1
    • Primarily linked to vitamin E acetate in THC-containing products 1
    • Presents with respiratory symptoms (cough, shortness of breath), gastrointestinal symptoms, and constitutional symptoms 2
    • Radiographically shows bilateral ground glass opacifications 3
  • Common respiratory effects:

    • Coughing, throat irritation, and shortness of breath 1
    • Bronchiolitis obliterans (from diacetyl, a common flavoring agent) 3
    • Increased risk of respiratory infections 2

Cardiovascular System Risks

  • Nicotine in e-cigarettes causes:
    • Increased blood pressure and heart rate 1
    • Narrowing of arteries 1
    • Potential contribution to coronary artery disease, atherosclerosis, aortic aneurysms 1
    • Irregular heartbeat 1
    • Particularly dangerous for those with pre-existing cardiovascular conditions 1, 4

Neurological Risks

  • Neurotoxic effects of nicotine:
    • Particularly harmful to developing brains 1
    • Affects learning, reasoning, and attention 1
    • Impacts impulse control and personality 1
    • Causes structural and functional alterations in brain areas related to emotion and decision-making 1
    • Increased risk for psychopathology 1

Chemical Exposure Risks

  • Harmful chemicals in vaping aerosols:
    • Propylene glycol and glycerin generate pulmonary irritants and carcinogenic compounds (formaldehyde, acetaldehyde, acrolein) when heated 3
    • Metals from heating coils and cartridges (aluminum, chromium, iron, lead, nickel, etc.) 3
    • Flavoring agents lack safety data for inhalation 3
    • Volatile organic compounds (VOCs) and particulates 5

Vulnerable Populations at Higher Risk

  • Adolescents and youth:

    • More vulnerable to addiction and nicotine's harmful effects 1
    • Disruption of brain development 1
    • Increased addiction vulnerability 1
    • Usage rates as high as 27.5% in high school students in 2019 4
  • Pregnant women:

    • Nicotine crosses the placenta affecting fetal development 1
    • Can lead to impaired fertility, type 2 diabetes, obesity, hypertension in offspring 1
    • Causes neurobehavioral defects and respiratory dysfunction in offspring 1
  • Individuals with pre-existing conditions:

    • Increased risk for those with respiratory or cardiovascular conditions 1
    • Compromised immune systems may be more vulnerable to effects 5

Environmental Risks

  • Secondhand exposure:

    • Aerosol contains nicotine and other harmful toxicants 1
    • Poses health risks to non-users, especially in enclosed spaces 1, 5
  • Thirdhand exposure:

    • Residue remains on surfaces and in dust 1
    • Can react with oxidants to yield secondary pollutants 1

Clinical Management of EVALI

For patients with suspected EVALI, the CDC recommends 2:

  1. Initial clinical assessment:

    • Vital signs, pulse oximetry
    • Focused history and physical exam
    • Rule out other possible etiologies (influenza, pneumonia)
  2. Determine if hospitalization is needed based on:

    • Oxygen saturation <95% on room air
    • Respiratory distress
    • Comorbidities that could compromise cardiopulmonary reserve
    • Inability to discontinue e-cigarette use
  3. For hospitalized patients:

    • Discontinue all e-cigarette and vaping product use
    • Consider corticosteroids (associated with clinical improvement)
    • Ensure follow-up within 48 hours after discharge
    • Schedule pulmonology follow-up within 2-4 weeks

Prevention and Recommendations

  • Healthcare providers should routinely screen for all tobacco product use, including e-cigarettes 1
  • Advise all patients, especially youth and non-smokers, to avoid initiating vaping 1
  • For smoking cessation, recommend FDA-approved nicotine replacement therapy and counseling rather than e-cigarettes 1
  • The American Heart Association, American Academy of Pediatrics, and American College of Cardiology recommend against using e-cigarettes for smoking cessation 1, 4

Important Caveats

  • Long-term health effects remain incompletely understood due to the relatively recent emergence of these products 1, 6
  • Rapidly evolving e-cigarette technology and formulations make standardized research challenging 1
  • While e-cigarettes may have lower levels of some toxicants than combustible cigarettes, they are not harmless and introduce their own unique risks 5, 6
  • Accidental poisonings in children from e-juice liquids have increased 5

References

Guideline

Health Risks of Vaping

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Review of Health Consequences of Electronic Cigarettes and the Outbreak of Electronic Cigarette, or Vaping, Product Use-Associated Lung Injury.

Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2020

Research

Electronic cigarettes in the indoor environment.

Reviews on environmental health, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.